| BAY-1436032 |
2-[[4-(三氟甲氧基)苯基]氨基]-1-[(1R,5R)-3,3,5-三甲基环己基]-1H-苯并咪唑-5-丙酸 |
1803274-65-8 |
| Methyl 2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazin-1-yl]benzoate |
2-[(1H-吡咯并[2,3-B]吡啶-5-基)氧基]-4-[4-[[2-(4-氯苯基)-4,4-二甲基环己-1-烯基]甲基]哌嗪-1-基]苯甲酸甲酯 |
1235865-76-5 |
| PI3Kδ-IN-2 |
YY-20394 |
1702816-75-8 |
| (4-fluorophenyl)(2-(piperazin-1-yl)pyrimidin-5-yl)methanone |
CPD1212-A6游离 |
1703794-75-5 |
| 4-(4-ethylpiperazin-1-yl)-2-nitroaniline |
0999-A4 |
1702260-52-3 |
| 1616710-52-1 |
1616710-52-1 |
1616710-52-1 |
| Ivabradine IMpurity |
伊伐布雷定杂质 |
1616710-50-9 |
| LDN-214117 |
无中文名称 |
1627503-67-6 |
| (R)-2-(1-amino-2-(2,5-dibromophenyl)ethyl)-5-bromopheno |
(R)-2-(1氨基-2-(2,5-二溴苯基)乙基)-5-溴苯酚 |
1585969-24-9 |
| Phenol, 5-bromo-2-[(2R)-5-bromo-2,3-dihydro-1H-indol-2-yl]- |
(R)-5-溴-2-(5-溴二氢吲哚-2-基)苯酚 |
1585969-17-0 |
| Treprostinil intermediate 1 |
[(4S)-4-羟基壬基]膦酸二甲酯 |
1593674-47-5 |
| B I09 |
B I09 |
1607803-67-7 |
| AMG319 |
AMG319 |
1608125-21-8 |
| STK16-IN-1 |
化合物STK16-IN-1 |
1223001-53-3 |
| 1R,3S-RSL 3 |
化合物1R,3S-RSL 3 |
1219810-13-5 |
| PF-06281355 |
1435467-38-1 |
1435467-38-1 |
| ND-646 |
ACC抑制剂(ND-646) |
1434639-57-2 |
| FX1 |
CS-2497 |
1426138-42-2 |
| HJC0152 |
2-(2-氨基乙氧基)-5-氯-N-(2-氯-4-硝基苯基)苯甲酰胺盐酸盐 |
1420290-99-8 |
| Lp-PLA2 -IN-1 |
1420367-28-7 |
1420367-28-7 |
